Literature DB >> 4005122

Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations.

V A John, S E Smith.   

Abstract

Plasma concentrations of oxprenolol have been measured in six healthy volunteers following single-dose oral administration of the drug in conventional and Oros dosage forms in fasting and postprandial states. After the Oros system, plasma concentrations reached peaks in most subjects at 3-8 h after dosing and were approximately 25% of those achieved with the conventional tablet. Plasma concentrations were well sustained for at least 24 h. A secondary peak occurred consistently at 12 h, possibly reflecting a transient change in clearance and/or distribution of the drug following the evening meal. With each formulation, plasma drug concentration profiles following administration in the fasting state did not differ significantly from those obtained when the drug was given postprandially. Drug absorption in vivo corresponded reasonably closely with in vitro drug release from the Oros system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005122      PMCID: PMC1463752          DOI: 10.1111/j.1365-2125.1985.tb02761.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography.

Authors:  P H Degen; W Riess
Journal:  J Chromatogr       Date:  1976-06-09

2.  Pharmacokinetics of oxprenolol in normal subjects.

Authors:  W D Mason; N Winer
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

3.  The effect of oral protein and glucose feeding of splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects.

Authors:  J L BRANDT; L CASTLEMAN; H D RUSKIN; J GREENWALD; J J KELLY
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

4.  Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors:  A Melander; K Danielson; B Scherstén; E Wåhlin
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

5.  Effect of food, food constituents and fluid volume on the bioavailability of sotalol.

Authors:  P Kahela; M Anttila; R Tikkanen; H Sundquist
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-01

6.  Mathematical basis of point-area deconvolution method for determining in vivo input functions.

Authors:  D P Vaughan; M Dennis
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

7.  Bioavailability of conventional and slow-release oxprenolol in fasted and nonfasted individuals.

Authors:  C P Dawes; M J Kendall; P G Welling
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

8.  Metabolism of isoprenaline in the intestine.

Authors:  C F George; E W Blackwell; D S Davies
Journal:  J Pharm Pharmacol       Date:  1974-04       Impact factor: 3.765

9.  Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolites.

Authors:  T Walle; T C Fagan; U K Walle; M J Oexmann; E C Conradi; T E Gaffney
Journal:  Clin Pharmacol Ther       Date:  1981-12       Impact factor: 6.875

10.  Reduction of first-pass hepatic clearance of propranolol by food.

Authors:  A J McLean; C Isbister; A Bobik; F J Dudley
Journal:  Clin Pharmacol Ther       Date:  1981-07       Impact factor: 6.875

View more
  5 in total

Review 1.  Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Authors:  P S Banerjee; J R Robinson
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

2.  Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy.

Authors:  S S Davis; N Washington; G D Parr; A H Short; V A John; P Lloyd; S M Walker
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

3.  Jejunal and ileal absorption of oxprenolol in man: influence of nutrients and digestive secretions on jejunal absorption and systemic availability.

Authors:  J Godbillon; N Vidon; R Palma; A Pfeiffer; C Franchisseur; M Bovet; G Gosset; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

4.  Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.

Authors:  G van den Berg; F van Steveninck; J M Gubbens-Stibbe; H C Schoemaker; A G de Boer; A F Cohen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food.

Authors:  Manisha Lamba; Rong Wang; Tracey Fletcher; Christine Alvey; Joseph Kushner; Thomas C Stock
Journal:  J Clin Pharmacol       Date:  2016-11       Impact factor: 3.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.